SC: Advocate Must Protect Client Confidentiality Even after Client Turns Adversary || SC: Revenue Record Mutation Alone Cannot Defeat a Person’s Property Title || SC: SARFAESI Auction Valid Despite EMD Shortfall Where 25% Price Was Paid on Auction Day || SC: Extended GST Limitation under S.74 Requires Notice to Specify Fraud or Concealment || Allahabad HC Invalidates Key Provisions of Uttar Pradesh Tenancy Law || Delhi HC: Writ Courts Cannot Prescribe Method for Determining Property Tax || Bombay HC: ICC’s ‘No Sexual Element’ Finding Can Be Challenged under POSH Act || Rajasthan HC: Road Widening Demolition Requires Title Claims and Fair Hearing || Allahabad HC: Mere Presence or FIR Nomination is Insufficient for Conviction under Section 149 IPC || MP HC: Employment Secured Through Forged Records Gives No Right to Hold Public Office

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT SELLING OF REMDESIVIR

Share :